PerkinElmer Ventures

PerkinElmer Ventures is the strategic investment fund of PerkinElmer, the Waltham-based science and diagnostics company. The arm directs capital into specialized diagnostic imaging and life sciences instrumentation, reflecting the parent’s franchises in newborn screening, reproductive health, applied genomics, imaging, and life sciences research. Founders building tools across prenatal and neonatal diagnostics, multiplexed imaging, automated liquid handling, environmental and food testing, and applied research instrumentation are within thesis. PerkinElmer’s combined diagnostics and applied markets footprint allows the venture arm to evaluate products that touch either clinical or research customer bases.

The fund invests at Series A and Series B with checks of $1M to $5M. It is based in the United States and concentrates on life sciences tools and diagnostics. No AI focus is stated, though imaging and screening workflows increasingly depend on computational analysis.

Founders should be ready to discuss integration with PerkinElmer’s screening, imaging, or applied genomics platforms, regulatory pathway for diagnostic candidates, and demand signals from clinical labs or pharma R&D. Limited public information is available about partner contacts or specific portfolio companies. The most credible entry path is typically through PerkinElmer business development, R&D leadership, or KOLs in newborn screening, reproductive health, or high content imaging who hold relationships with the company.